The role of radiation in retroperitoneal sarcomas

Current Treatment Options in Oncology

Volumn 14, Issue 3, 2013, Pages 425-441

  Mohindra, Pranshu ^a   Neuman, Heather B ^b   Kozak, Kevin R ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Carbon ion radiotherapy; Image guided radiotherapy; Prognostic factors, Literature review, Aggressive surgical resections, Modern radiotherapy techniques, Intensity modulated radiotherapy; Proton beam radiotherapy; Radiotherapy; Radiotherapy dose escalation; Radiotherapy dose response; Retroperitoneal sarcoma

Indexed keywords

ARTICLE; CANCER SURGERY; DOSE RESPONSE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; OVERALL SURVIVAL; PEROPERATIVE CARE; PHOTON THERAPY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE ESCALATION; RADIATION SAFETY; RETROPERITONEAL SARCOMA; RISK ASSESSMENT; TISSUE DISTRIBUTION; TREATMENT INDICATION; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROPERITONEAL NEOPLASMS; SARCOMA; TREATMENT OUTCOME;

EID: 84884202579     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-013-0236-6     Document Type: Article

References (56)

1. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355-65. PMCID: 1191491.
2. Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol. 2002;65(3):137-43.
3. Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg. 2009;250(6):970-6. PMCID: 3099434.
4. Mullinax JE, Zager JS, Gonzalez RJ. Current diagnosis and management of retroperitoneal sarcoma. Cancer Control. 2011;18(3):177-87.
5. Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007;94(2):145-61.
6. Learn PA, Bach PB. A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care. 2010;48(12):1041-9. Mortality reduction seen in the analysis presented in this study stresses the need to refer patients needing complicated surgery to tertiary care centers. Significant mortality reductions is noted.
7. Gutierrez JC, Perez EA, Franceschi D, et al. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res. 2007;141(1):105-14.
8. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31-7. This multi-institutional, French experience describes importance of aggressive surgical resection but unlike the Italian experience (Gronchi et al.) raises questions on the role of radiotherapy in this setting.
9. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;50(1):127-31.
10. Youssef E, Fontanesi J, Mott M, et al. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys. 2002;54(2):514-9.
11. Zlotecki RA, Katz TS, Morris CG, et al. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol. 2005;28(3):310-6.
12. Krempien R, Roeder F, Oertel S, et al. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2006;65(3):773-9.
13. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24-30. This is a modern, single-institutional experience describing impact of aggressive surgical resection in improving local control rates for RPS. Survival benefit was seen with addition of RT in the population, though benefit was smaller with more aggressive resection.
14. McBride SM, Raut CP, Lapidus M, et al. Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose Escalation. Ann Surg Oncol. 2013;Epub ahead of print. In this recent series, poor prognostic implication of multifocality is noted on multivariate analysis for RFS.
15. Alford S, Choong P, Chander S, et al. Outcomes of preoperative radiotherapy and resection of retroperitoneal sarcoma. ANZ J Surg. 2012;Epub ahead of print.
16. Van De Voorde L, Delrue L, van Eijkeren M, De Meerleer G. Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer. 2011;117(19):4355-64.
17. Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. Ann R Coll Surg Engl. 2011;93(4):275-80. PMCID: 3363075.
18. Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg. 1991;126(3):328-34.
19. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221(2):185-95. PMCID: 1234952.
20. Kilkenny 3rd JW, Bland KI, Copeland 3rd EM. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182(4):329-39.
21. Shiloni E, Szold A, White DE, Freund HR. High-grade retroperitoneal sarcomas: role of an aggressive palliative approach. J Surg Oncol. 1993;53(3):197-203.
22. McGrath PC, Neifeld JP, Lawrence Jr W, et al. Improved survival following complete excision of retroperitoneal sarcomas. Ann Surg. 1984;200(2):200-4. PMCID: 1250445.
23. Glenn J, Sindelar WF, Kinsella T, et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985;97(3):316-25.
24. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128(4):402-10.
25. Fein DA, Corn BW, Lanciano RM, et al. Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys. 1995;31(1):129-34.
26. Feng M, Murphy J, Griffith KA, et al. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007;69(1):103-10.
27. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67(1):158-63.
28. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235-41.
29. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006;106(7):1610-6.
30. Tseng WH, Martinez SR, Do L, et al. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res. 2011;168(2):e173-80. In this SEER analysis, survival advantage was suggested with use of RT in intermediate grade and MFH histology patients.
31. Sampath S, Hitchcock YJ, Shrieve DC, et al. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 2010;101(5):345-50. In this large multi-institutional experience, use of RT improved local control rates when performing a simple surgical resection, while no benefit was seen if a wide resection wsa performed.
32. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92(2):359-68.
33. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52(2):469-75.
34. Donahue TR, Kattan MW, Nelson SD, et al. Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram. Cancer. 2010;116(16):3883-91.
35. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791-6.
36. Paryani NN, Zlotecki RA, Swanson EL, et al. Multimodality local therapy for retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys. 2012;82(3):1128-34.
37. Fuks D, Verhaeghe JL, Marchal F, et al. Surgery and postoperative radiation therapy in primary retroperitoneal sarcomas: experience of the cancer centre Alexis-Vautrin. Cancer Radiother. 2012;16(3):194-200.
38. Le Pechoux C, Musat E, Baey C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol. 2013;24(3):832-7. This is a modern series that describes use of PORT in setting of aggressive surgical resection. Despite selection bias with unfavorble histological features in the RT arm, relapse-free survival and abdominal relapse was significantly lower in the RT arm. In this series, tissue expanders or omentoplasty was used to displace bowel from surgical bed.
39. Zhou Z, McDade TP, Simons JP, et al. Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg. 2010;145(5):426-31. In this SEER analysis, after stage adjustment, survival advantage was noted with use of RT in stage I but not for stage II/ III.
40. Choi AH, Barnholtz-Sloan JS, Kim JA. Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol. 2012;23(9):2449-57. To correct for heterogeneity in patient populatioin noted in all SEER data analyses, the authors performed a propensity-score adjusted, matched-pair analysis to demonstrate that RT did not contribute to survival. Impact on local control was not analysable in this database.
41. Pezner RD, Liu A, Han C, et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother Oncol. 2006;81(1):81-7.
42. Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006;107(2):371-9.
43. Bossi A, De Wever I, Van Limbergen E, Vanstraelen B. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys. 2007;67(1):164-70.
44. Paumier A, Le Pechoux C, Beaudre A, et al. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma? Radiother Oncol. 2011;99(1):73-8. In this dosimetric study, superiority of IMRT over 3D-conformal RT to reduce radiation dose to normal tissues is demonstrated. Dose-constraints presented in the study may be referred to for IMRT planning.
45. Yoon SS, Chen YL, Kirsch DG, et al. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol. 2010;17(6):1515-29. A modern series describing clinical experiene with use of IMRT and Proton beam RT in management of RPS. Dose-constraints presented in the study may be referred to for IMRT and proton beam RT planning.
46. Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys. 2012;83(5):1549-57. This study demonstrates dosimetric superiority of 3D-conformal proton beam RT over IMRT and 3D-conformal photon RT. Dose-constraints presented in the study may be referred to for IMRT planning.
47. Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2009;75(4):1105-10.
48. Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006;13(4):508-17.
49. Roeder F, Schulz-Ertner D, Nikoghosyan AV, et al. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma. BMC Cancer. 2012;12:287. This is a prospective phase I/II study aiming to use dose-escalated IMRT along with IORT to improve treatment outcomes. Results of this study are awaited.
50. Lee HJ, Song SY, Kwon TW, et al. Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma. Radiat Oncol J. 2011;29(4):260-8.
51. Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20(12):2824-31.
52. Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007;25(19):2755-63.
53. Pautier P, Floquet A, Penel N, et al. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). Oncologist. 2012;17(9):1213-20.
54. Jones JJ, Catton CN, O'Sullivan B, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9(4):346-54.
55. White JS, Biberdorf D, DiFrancesco LM, et al. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann Surg Oncol. 2007;14(2):583-90.
56. Pezner RD, Liu A, Chen YJ, et al. Full-dose adjuvant postoperative radiation therapy for retroperitoneal sarcomas. Am J Clin Oncol. 2011;34(5):511-6.